None listed
Conditions
Interventions
Intervention1: chloroprocaine 1%: Intrathecal chloroprocaine 3.4 ml (1%) with 0.1 ml normal saline
Control Intervention1: Dexmedetomidine 10 microgram: Intrathecal chloroprocaine 3.4 ml (1%) with 0.1
Sponsors
Department of Anaesthesiology
Eligibility
Inclusion criteria
Inclusion criteria: ASA I and II Full term pregnant female posted for lscs
Exclusion criteria
Exclusion criteria: Pregnancy with PIH severe anemia Cardiac and Respiratory Disease Drug Allergy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Onset, duration and quality of sensory and motor block. Timepoint: 24 hours postoperatively | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of analgesia Any side effectsTimepoint: 24 hours postoperatively | — |
Countries
India
Contacts
Public ContactYogendra Singhal
RNT Medical College
Outcome results
None listed